Financials EnBio Holdings, Inc

Equities

6092

JP3169730003

Environmental Services & Equipment

Delayed Japan Exchange 09:46:58 2024-07-11 pm EDT 5-day change 1st Jan Change
634 JPY +0.96% Intraday chart for EnBio Holdings, Inc -3.06% +6.73%

Valuation

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024
Capitalization 1 4,140 3,680 4,223 5,517 5,039 4,899
Enterprise Value (EV) 1 13,697 8,801 11,243 11,727 11,107 9,913
P/E ratio -27.5 x 6.7 x 14 x 8.43 x 6.21 x 6.78 x
Yield - - - 0.96% 1.05% -
Capitalization / Revenue 0.48 x 0.5 x 0.62 x 0.61 x 0.62 x 0.51 x
EV / Revenue 1.6 x 1.19 x 1.64 x 1.3 x 1.37 x 1.04 x
EV / EBITDA 12 x 8 x 11.4 x 7.4 x 6.32 x 7.9 x
EV / FCF -14.3 x 10.8 x -6.58 x 13.1 x -18.6 x 127 x
FCF Yield -7% 9.23% -15.2% 7.61% -5.37% 0.78%
Price to Book 0.96 x 0.75 x 0.81 x 0.94 x 0.74 x 0.58 x
Nbr of stocks (in thousands) 6,499 6,571 6,578 6,647 6,638 8,137
Reference price 2 637.0 560.0 642.0 830.0 759.0 602.0
Announcement Date 6/24/19 6/29/20 6/28/21 6/27/22 6/28/23 6/27/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024
Net sales 1 8,563 7,408 6,840 8,987 8,120 9,575
EBITDA 1 1,145 1,100 985 1,585 1,758 1,254
EBIT 1 637 674 618 1,244 1,358 816
Operating Margin 7.44% 9.1% 9.04% 13.84% 16.72% 8.52%
Earnings before Tax (EBT) 1 -60 833 488 1,098 1,233 1,064
Net income 1 -150 555 304 654 812 708
Net margin -1.75% 7.49% 4.44% 7.28% 10% 7.39%
EPS 2 -23.21 83.64 45.76 98.47 122.3 88.75
Free Cash Flow 1 -958.4 812 -1,709 892.6 -596.8 77.75
FCF margin -11.19% 10.96% -24.98% 9.93% -7.35% 0.81%
FCF Conversion (EBITDA) - 73.82% - 56.32% - 6.2%
FCF Conversion (Net income) - 146.31% - 136.49% - 10.98%
Dividend per Share - - - 8.000 8.000 -
Announcement Date 6/24/19 6/29/20 6/28/21 6/27/22 6/28/23 6/27/24
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Marzo 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 3,621 4,301 3,039 2,668 5,636 1,135 3,423 5,482 1,504
EBITDA - - - - - - - - -
EBIT 1 410 702 368 715 1,378 -18 240 409 58
Operating Margin 11.32% 16.32% 12.11% 26.8% 24.45% -1.59% 7.01% 7.46% 3.86%
Earnings before Tax (EBT) 1 394 581 379 732 1,451 -161 345 547 -3
Net income 1 263 375 205 480 972 -116 170 321 24
Net margin 7.26% 8.72% 6.75% 17.99% 17.25% -10.22% 4.97% 5.86% 1.6%
EPS 2 40.15 56.62 30.90 72.28 146.4 -17.45 22.79 41.11 2.450
Dividend per Share - - - - - - - - -
Announcement Date 11/13/20 11/12/21 2/14/22 8/12/22 11/14/22 2/13/23 8/14/23 11/14/23 2/14/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024
Net Debt 1 9,557 5,121 7,020 6,210 6,068 5,014
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 8.347 x 4.655 x 7.127 x 3.918 x 3.452 x 3.998 x
Free Cash Flow 1 -958 812 -1,709 893 -597 77.8
ROE (net income / shareholders' equity) -3.49% 11.5% 6.49% 12.5% 12.4% 9.56%
ROA (Net income/ Total Assets) 2.14% 2.54% 2.51% 4.85% 5.03% 2.78%
Assets 1 -7,002 21,815 12,094 13,487 16,130 25,447
Book Value Per Share 2 666.0 744.0 795.0 886.0 1,023 1,044
Cash Flow per Share 2 360.0 454.0 303.0 357.0 426.0 443.0
Capex 1 627 357 1,729 1,164 1,162 1,079
Capex / Sales 7.32% 4.82% 25.28% 12.95% 14.31% 11.27%
Announcement Date 6/24/19 6/29/20 6/28/21 6/27/22 6/28/23 6/27/24
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 6092 Stock
  4. Financials EnBio Holdings, Inc